These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20656484)

  • 1. Modification at the acidic domain of RXR agonists has little effect on permissive RXR-heterodimer activation.
    Fujii S; Ohsawa F; Yamada S; Shinozaki R; Fukai R; Makishima M; Enomoto S; Tai A; Kakuta H
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5139-42. PubMed ID: 20656484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent retinoid X receptor ligands for fluorescence polarization assay.
    Yamada S; Ohsawa F; Fujii S; Shinozaki R; Makishima M; Naitou H; Enomoto S; Tai A; Kakuta H
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5143-6. PubMed ID: 20667726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid X receptors: common heterodimerization partners with distinct functions.
    Lefebvre P; Benomar Y; Staels B
    Trends Endocrinol Metab; 2010 Nov; 21(11):676-83. PubMed ID: 20674387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective allosteric ligand activation of the retinoid X receptor heterodimers of NGFI-B and Nurr1.
    Morita K; Kawana K; Sodeyama M; Shimomura I; Kagechika H; Makishima M
    Biochem Pharmacol; 2005 Dec; 71(1-2):98-107. PubMed ID: 16288995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved retinoid X receptor (RXR) from the mollusk Biomphalaria glabrata transactivates transcription in the presence of retinoids.
    Bouton D; Escriva H; de Mendonça RL; Glineur C; Bertin B; Noël C; Robinson-Rechavi M; de Groot A; Cornette J; Laudet V; Pierce RJ
    J Mol Endocrinol; 2005 Apr; 34(2):567-82. PubMed ID: 15821117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
    Lammi J; Perlmann T; Aarnisalo P
    Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.
    Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X
    J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Challenge of creating single-agents for the treatment of type 1 and 2 diabetes by targeting retinoid X receptor].
    Kakuta H
    Yakugaku Zasshi; 2011; 131(6):917-23. PubMed ID: 21628978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS; Szanto A; Nagy L; Davies PJ
    J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPARδ-RXR.
    Nakashima KI; Yamaguchi E; Noritake C; Mitsugi Y; Goto M; Hirai T; Abe N; Sakai E; Oyama M; Itoh A; Inoue M
    ACS Chem Biol; 2020 Jun; 15(6):1526-1534. PubMed ID: 32374156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of benzofused heterocyclic RXR modulators.
    Gernert DL; Neel DA; Boehm MF; Leibowitz MD; Mais DA; Michellys PY; Rungta D; Reifel-Miller A; Grese TA
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2759-63. PubMed ID: 15125928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoid X receptor ligands: a patent review (2007 - 2013).
    Yamada S; Kakuta H
    Expert Opin Ther Pat; 2014 Apr; 24(4):443-52. PubMed ID: 24456080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells.
    Chai D; Wang B; Shen L; Pu J; Zhang XK; He B
    Free Radic Biol Med; 2008 Apr; 44(7):1334-47. PubMed ID: 18206668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
    Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
    Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
    Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
    EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
    Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
    Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potency.
    Ohsawa F; Yamada S; Yakushiji N; Shinozaki R; Nakayama M; Kawata K; Hagaya M; Kobayashi T; Kohara K; Furusawa Y; Fujiwara C; Ohta Y; Makishima M; Naitou H; Tai A; Yoshikawa Y; Yasui H; Kakuta H
    J Med Chem; 2013 Mar; 56(5):1865-77. PubMed ID: 23391145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first potent subtype-selective retinoid X receptor (RXR) agonist possessing a 3-isopropoxy-4-isopropylphenylamino moiety, NEt-3IP (RXRalpha/beta-dual agonist).
    Takamatsu K; Takano A; Yakushiji N; Morohashi K; Morishita K; Matsuura N; Makishima M; Tai A; Sasaki K; Kakuta H
    ChemMedChem; 2008 May; 3(5):780-7. PubMed ID: 18297677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.